Songfeng C. Wei
Department Of Thyroid And Neck Cancer, Key Laboratory Of Cancer Prevention And Therapy
Tianjin, 300060, China
Tianjin, 300060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
A novel tetramethylpyrazine derivative inhibits thyroid cancer progression by epigenetically activating the DUSP19-mediated JNK signaling pathway.
Journal: Acta biochimica et biophysica Sinica
Published: May 18, 2026
Enhancer-mediated NR2F2 recruitment activates BGN to promote tumor growth and shape tumor microenvironment in papillary thyroid cancer.
Journal: Theranostics
Published: March 13, 2025
Identification of stemness subtypes and prognostic modeling in thyroid cancer: the critical role of DPYSL3 in tumor progression and immune microenvironment.
Journal: Discover oncology
Published: March 05, 2025
The SOX12-YBX1-LDHA signaling axis drives metastasis in papillary thyroid carcinoma.
Journal: Cell death & disease
Published: October 30, 2024
SETMAR Facilitates the Differentiation of Thyroid Cancer by Regulating SMARCA2-Mediated Chromatin Remodeling.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 17, 2024
Multidimensional data analysis revealed thyroiditis-associated TCF19 SNP rs2073724 as a highly ranked protective variant in thyroid cancer.
Journal: Aging
Published: November 24, 2023
PARP inhibitor shuts down the global translation of thyroid cancer through promoting Pol II binding to DIMT1 pause.
Journal: International journal of biological sciences
Published: December 15, 2022
To Explore the Inhibitory Mechanism of Quercetin in Thyroid Papillary Carcinoma through Network Pharmacology and Experiments.
Journal: Disease markers
Published: August 25, 2022
Indoleamine 2,3-dioxygenase 2 immunohistochemical expression in medullary thyroid carcinoma: implications in prognosis and immunomodulatory effects.
Journal: BMC cancer
Published: June 13, 2022
Last Updated: 09/26/2026